Gemma Jacklyn, Paul Glasziou, Petra Macaskill, Alexandra Barratt. Br J Cancer 2016
Times Cited: 26
Times Cited: 26
Times Cited
Times Co-cited
Similarity
26
The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
23
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
Jamie L Carter, Russell J Coletti, Russell P Harris. BMJ 2015
Jamie L Carter, Russell J Coletti, Russell P Harris. BMJ 2015
19
Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Les Irwig, Kevin McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami, Kirsten McCaffery. Lancet 2015
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Les Irwig, Kevin McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami, Kirsten McCaffery. Lancet 2015
15
Screening for breast cancer with mammography.
Peter C Gøtzsche, Karsten Juhl Jørgensen. Cochrane Database Syst Rev 2013
Peter C Gøtzsche, Karsten Juhl Jørgensen. Cochrane Database Syst Rev 2013
15
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Albert L Siu. Ann Intern Med 2016
Albert L Siu. Ann Intern Med 2016
15
Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Charles Harding, Francesco Pompei, Dmitriy Burmistrov, H Gilbert Welch, Rediet Abebe, Richard Wilson. JAMA Intern Med 2015
Charles Harding, Francesco Pompei, Dmitriy Burmistrov, H Gilbert Welch, Rediet Abebe, Richard Wilson. JAMA Intern Med 2015
15
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Stephen Morrell, Alexandra Barratt, Les Irwig, Kirsten Howard, Corné Biesheuvel, Bruce Armstrong. Cancer Causes Control 2010
Stephen Morrell, Alexandra Barratt, Les Irwig, Kirsten Howard, Corné Biesheuvel, Bruce Armstrong. Cancer Causes Control 2010
11
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
Heidi D Nelson, Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
11
Abolishing mammography screening programs? A view from the Swiss Medical Board.
Nikola Biller-Andorno, Peter Jüni. N Engl J Med 2014
Nikola Biller-Andorno, Peter Jüni. N Engl J Med 2014
11
Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.
Jolyn Hersch, Jesse Jansen, Alexandra Barratt, Les Irwig, Nehmat Houssami, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Kirsten McCaffery. BMJ Open 2014
Jolyn Hersch, Jesse Jansen, Alexandra Barratt, Les Irwig, Nehmat Houssami, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Kirsten McCaffery. BMJ Open 2014
14
Improving communication about cancer screening: moving towards informed decision making.
Jolyn K Hersch, Brooke L Nickel, Alex Ghanouni, Jesse Jansen, Kirsten J McCaffery. Public Health Res Pract 2017
Jolyn K Hersch, Brooke L Nickel, Alex Ghanouni, Jesse Jansen, Kirsten J McCaffery. Public Health Res Pract 2017
11
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
11
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
Anthony B Miller, Claus Wall, Cornelia J Baines, Ping Sun, Teresa To, Steven A Narod. BMJ 2014
Anthony B Miller, Claus Wall, Cornelia J Baines, Ping Sun, Teresa To, Steven A Narod. BMJ 2014
11
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
11
Effect of three decades of screening mammography on breast-cancer incidence.
Archie Bleyer, H Gilbert Welch. N Engl J Med 2012
Archie Bleyer, H Gilbert Welch. N Engl J Med 2012
11
Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
7
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Mette Kalager, Hans-Olov Adami, Michael Bretthauer, Rulla M Tamimi. Ann Intern Med 2012
Mette Kalager, Hans-Olov Adami, Michael Bretthauer, Rulla M Tamimi. Ann Intern Med 2012
7
The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.
Jeanette Birnbaum, Vijayakrishna K Gadi, Elan Markowitz, Ruth Etzioni. Ann Intern Med 2016
Jeanette Birnbaum, Vijayakrishna K Gadi, Elan Markowitz, Ruth Etzioni. Ann Intern Med 2016
7
Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women.
Erin Mathieu, Alexandra Barratt, Heather M Davey, Kevin McGeechan, Kirsten Howard, Nehmat Houssami. Arch Intern Med 2007
Erin Mathieu, Alexandra Barratt, Heather M Davey, Kevin McGeechan, Kirsten Howard, Nehmat Houssami. Arch Intern Med 2007
7
Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review.
Corné Biesheuvel, Alexandra Barratt, Kirsten Howard, Nehmat Houssami, Les Irwig. Lancet Oncol 2007
Corné Biesheuvel, Alexandra Barratt, Kirsten Howard, Nehmat Houssami, Les Irwig. Lancet Oncol 2007
7
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, Per-Henrik Zahl. Ann Intern Med 2017
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, Per-Henrik Zahl. Ann Intern Med 2017
7
Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Colin Luke, Kevin Priest, David Roder. Asian Pac J Cancer Prev 2006
Colin Luke, Kevin Priest, David Roder. Asian Pac J Cancer Prev 2006
18
Tumor characteristics and clinical outcome of elderly women with breast cancer.
S G Diab, R M Elledge, G M Clark. J Natl Cancer Inst 2000
S G Diab, R M Elledge, G M Clark. J Natl Cancer Inst 2000
7
Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
Lennarth Nyström, Ingvar Andersson, Nils Bjurstam, Jan Frisell, Bo Nordenskjöld, Lars Erik Rutqvist. Lancet 2002
Lennarth Nyström, Ingvar Andersson, Nils Bjurstam, Jan Frisell, Bo Nordenskjöld, Lars Erik Rutqvist. Lancet 2002
7
Benefits and harms of mammography screening.
Magnus Løberg, Mette Lise Lousdal, Michael Bretthauer, Mette Kalager. Breast Cancer Res 2015
Magnus Løberg, Mette Lise Lousdal, Michael Bretthauer, Mette Kalager. Breast Cancer Res 2015
7
Quantifying the benefits and harms of screening mammography.
H Gilbert Welch, Honor J Passow. JAMA Intern Med 2014
H Gilbert Welch, Honor J Passow. JAMA Intern Med 2014
7
The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Nehmat Houssami, Les Irwig, Gemma Jacklyn, Haryana Dhillon, Hazel Thornton, Kevin McGeechan, Kirsten Howard,[...]. BMJ Open 2014
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Nehmat Houssami, Les Irwig, Gemma Jacklyn, Haryana Dhillon, Hazel Thornton, Kevin McGeechan, Kirsten Howard,[...]. BMJ Open 2014
7
Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.
Michael Edward Stefanek. J Natl Cancer Inst 2011
Michael Edward Stefanek. J Natl Cancer Inst 2011
7
Latent class instrumental variables: a clinical and biostatistical perspective.
Stuart G Baker, Barnett S Kramer, Karen S Lindeman. Stat Med 2016
Stuart G Baker, Barnett S Kramer, Karen S Lindeman. Stat Med 2016
12
Lead time and overdiagnosis.
Stuart G Baker, Philip C Prorok, Barnett S Kramer. J Natl Cancer Inst 2014
Stuart G Baker, Philip C Prorok, Barnett S Kramer. J Natl Cancer Inst 2014
11
Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.
Theodora M Ripping, Kevin Ten Haaf, André L M Verbeek, Nicolien T van Ravesteyn, Mireille J M Broeders. J Natl Cancer Inst 2017
Theodora M Ripping, Kevin Ten Haaf, André L M Verbeek, Nicolien T van Ravesteyn, Mireille J M Broeders. J Natl Cancer Inst 2017
8
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
Stephen W Duffy, Dharmishta Parmar. Breast Cancer Res 2013
Stephen W Duffy, Dharmishta Parmar. Breast Cancer Res 2013
7
Persuasive Interventions for Controversial Cancer Screening Recommendations: Testing a Novel Approach to Help Patients Make Evidence-Based Decisions.
Barry G Saver, Kathleen M Mazor, Roger Luckmann, Sarah L Cutrona, Marcela Hayes, Tatyana Gorodetsky, Nancy Esparza, Gonzalo Bacigalupe. Ann Fam Med 2017
Barry G Saver, Kathleen M Mazor, Roger Luckmann, Sarah L Cutrona, Marcela Hayes, Tatyana Gorodetsky, Nancy Esparza, Gonzalo Bacigalupe. Ann Fam Med 2017
28
To nudge or not to nudge: cancer screening programmes and the limits of libertarian paternalism.
Thomas Ploug, Søren Holm, John Brodersen. J Epidemiol Community Health 2012
Thomas Ploug, Søren Holm, John Brodersen. J Epidemiol Community Health 2012
7
Ethical issues with colorectal cancer screening-a systematic review.
Bjørn Hofmann. J Eval Clin Pract 2017
Bjørn Hofmann. J Eval Clin Pract 2017
16
Methods to increase participation in organised screening programs: a systematic review.
Laura Camilloni, Eliana Ferroni, Beatriz Jimenez Cendales, Annamaria Pezzarossi, Giacomo Furnari, Piero Borgia, Gabriella Guasticchi, Paolo Giorgi Rossi. BMC Public Health 2013
Laura Camilloni, Eliana Ferroni, Beatriz Jimenez Cendales, Annamaria Pezzarossi, Giacomo Furnari, Piero Borgia, Gabriella Guasticchi, Paolo Giorgi Rossi. BMC Public Health 2013
7
Promoting mammography screening among Chinese American women using a message-framing intervention.
Yiyuan Sun, Elizabeth A Sarma, Anne Moyer, Catherine R Messina. Patient Educ Couns 2015
Yiyuan Sun, Elizabeth A Sarma, Anne Moyer, Catherine R Messina. Patient Educ Couns 2015
14
Challenges of informed choice in organised screening.
W Østerlie, M Solbjør, J-A Skolbekken, S Hofvind, A R Saetnan, S Forsmo. J Med Ethics 2008
W Østerlie, M Solbjør, J-A Skolbekken, S Hofvind, A R Saetnan, S Forsmo. J Med Ethics 2008
7
Information about screening - is it to achieve high uptake or to ensure informed choice?
A E Raffle. Health Expect 2001
A E Raffle. Health Expect 2001
7
Cancer screening campaigns--getting past uninformative persuasion.
Steven Woloshin, Lisa M Schwartz, William C Black, Barnett S Kramer. N Engl J Med 2012
Steven Woloshin, Lisa M Schwartz, William C Black, Barnett S Kramer. N Engl J Med 2012
7
The ethics of information: absolute risk reduction and patient understanding of screening.
Peter H Schwartz, Eric M Meslin. J Gen Intern Med 2008
Peter H Schwartz, Eric M Meslin. J Gen Intern Med 2008
10
Seeking better health care outcomes: the ethics of using the "nudge".
J S Blumenthal-Barby, Hadley Burroughs. Am J Bioeth 2012
J S Blumenthal-Barby, Hadley Burroughs. Am J Bioeth 2012
7
Informed choice requires information about both benefits and harms.
K J Jørgensen, J Brodersen, O J Hartling, M Nielsen, P C Gøtzsche. J Med Ethics 2009
K J Jørgensen, J Brodersen, O J Hartling, M Nielsen, P C Gøtzsche. J Med Ethics 2009
7
Screening: The information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening.
Paolo Giorgi Rossi. BMC Med Ethics 2014
Paolo Giorgi Rossi. BMC Med Ethics 2014
28
The breast screening programme and misinforming the public.
Peter C Gøtzsche, Karsten Juhl Jørgensen. J R Soc Med 2011
Peter C Gøtzsche, Karsten Juhl Jørgensen. J R Soc Med 2011
7
Nudges in public health: paternalism is paramount.
Marcel Verweij, Mariëtte van den Hoven. Am J Bioeth 2012
Marcel Verweij, Mariëtte van den Hoven. Am J Bioeth 2012
18
Threat Appeals: The Fear-Persuasion Relationship is Linear and Curvilinear.
James Price Dillard, Ruobing Li, Yan Huang. Health Commun 2017
James Price Dillard, Ruobing Li, Yan Huang. Health Commun 2017
18
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.